A detailed history of Jane Street Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 20,024 shares of AMGN stock, worth $5.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,024
Previous 422,292 95.26%
Holding current value
$5.27 Million
Previous $132 Million 95.11%
% of portfolio
0.0%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $124 Million - $136 Million
-402,268 Reduced 95.26%
20,024 $6.45 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $43.3 Million - $52.6 Million
164,633 Added 63.9%
422,292 $132 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $31.9 Million - $38.5 Million
-118,556 Reduced 31.51%
257,659 $73.3 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $30.3 Million - $34.2 Million
-118,615 Reduced 23.97%
376,215 $108 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $85.1 Million - $106 Million
389,147 Added 368.22%
494,830 $133 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $13.2 Million - $15.6 Million
61,498 Added 139.18%
105,683 $23.5 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $11.5 Million - $14 Million
-50,915 Reduced 53.54%
44,185 $10.7 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $12.3 Million - $15.6 Million
53,497 Added 128.59%
95,100 $25 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $70.5 Million - $79.5 Million
-314,095 Reduced 88.3%
41,603 $9.38 Million
Q2 2022

Aug 16, 2022

BUY
$230.71 - $256.74 $65.3 Million - $72.7 Million
283,190 Added 390.56%
355,698 $86.5 Million
Q1 2022

May 17, 2022

BUY
$219.27 - $242.57 $1.49 Million - $1.65 Million
6,812 Added 10.37%
72,508 $17.5 Million
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $4.45 Million - $5.1 Million
22,393 Added 51.71%
65,696 $14.8 Million
Q3 2021

Nov 16, 2021

SELL
$212.27 - $248.7 $18.6 Million - $21.8 Million
-87,595 Reduced 66.92%
43,303 $9.21 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $4.69 Million - $5.2 Million
20,061 Added 18.1%
130,898 $31.9 Million
Q1 2021

May 18, 2021

BUY
$221.91 - $258.6 $12.1 Million - $14.1 Million
54,580 Added 97.02%
110,837 $27.6 Million
Q4 2020

Feb 17, 2021

SELL
$216.38 - $257.67 $1.14 Million - $1.36 Million
-5,276 Reduced 8.57%
56,257 $12.9 Million
Q3 2020

Nov 17, 2020

BUY
$234.65 - $260.95 $8.41 Million - $9.35 Million
35,846 Added 139.55%
61,533 $15.6 Million
Q2 2020

Aug 17, 2020

SELL
$197.81 - $242.74 $6.65 Million - $8.17 Million
-33,640 Reduced 56.7%
25,687 $6.06 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $2.89 Million - $3.83 Million
-15,858 Reduced 21.09%
59,327 $12 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $9.53 Million - $12.2 Million
50,354 Added 202.79%
75,185 $18.1 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $2.68 Million - $3.21 Million
-15,376 Reduced 38.24%
24,831 $4.81 Million
Q2 2019

Aug 15, 2019

SELL
$166.7 - $195.41 $10.7 Million - $12.5 Million
-64,137 Reduced 61.47%
40,207 $7.41 Million
Q1 2019

May 16, 2019

BUY
$180.87 - $203.88 $3.68 Million - $4.15 Million
20,343 Added 24.22%
104,344 $19.8 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $2.2 Million - $2.57 Million
12,354 Added 17.24%
84,001 $16.4 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $551,793 - $622,074
-2,978 Reduced 3.99%
71,647 $14.9 Million
Q2 2018

Aug 15, 2018

BUY
$166.05 - $186.51 $9.29 Million - $10.4 Million
55,966 Added 299.94%
74,625 $13.8 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $6.67 Million - $7.79 Million
-39,367 Reduced 67.84%
18,659 $3.18 Million
Q4 2017

Feb 15, 2018

SELL
$168.79 - $188.59 $12.1 Million - $13.5 Million
-71,521 Reduced 55.21%
58,026 $10.1 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $21.7 Million - $24.7 Million
129,547
129,547 $24.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.